Femasys (FEMY) Shares Outstanding (2020 - 2026)
Femasys' (FEMY) quarterly Shares Outstanding (Entity) came in at $4.6 million in Q1 2026, up 238.63% YoY from $1.4 million in Q1 2025, and up 132.94% on a QoQ basis from $2.0 million in Q4 2025.
Femasys (FEMY) Shares Outstanding (2020 - 2026) Analysis & Trends
Femasys (FEMY) has 7 years of Shares Outstanding (Entity) data on file, last reported at $4.6 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 238.63% year-over-year to $4.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.6 million (up 238.63% YoY) and the FY2025 annual result came in at $2.0 million, up 68.49% from the prior year.
- Shares Outstanding (Entity) rose to $4.6 million in Q1 2026, from $2.0 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $4.6 million in Q1 2026 to a low of $596069.0 in Q1 2022.
- A 5-year average of $1.3 million and a median of $1.1 million in 2024 frame the typical range for Shares Outstanding (Entity).
- The widest YoY moves for Shares Outstanding (Entity): up 1097.89% in 2022, down 0.12% in 2022.
- Tracing FEMY's Shares Outstanding (Entity) over 5 years: stood at $599346.0 in 2022, then gained by 28.34% to $769219.0 in 2023, then jumped by 52.58% to $1.2 million in 2024, then jumped by 68.49% to $2.0 million in 2025, then surged by 132.94% to $4.6 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $4.6 million (Q1 2026), $2.0 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 354.10 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 274.79 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 486.70 Mn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 145.52 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 857.00 Mn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 70.80 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 172.70 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 195.00 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 517.00 Mn |
| 10 | Femasys | 8.98 Mn | 7.54 Mn | 189,391.00 | 3.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.61 Mn |
| Dec 31, 2025 | 1.98 Mn |
| Sep 30, 2025 | 2.05 Mn |
| Jun 30, 2025 | 1.44 Mn |
| Mar 31, 2025 | 1.26 Mn |
| Dec 31, 2024 | 1.11 Mn |
| Sep 30, 2024 | 1.11 Mn |
| Jun 30, 2024 | 1.11 Mn |
| Mar 31, 2024 | 1.09 Mn |
| Dec 31, 2023 | 769,219.00 |
| Sep 30, 2023 | 754,657.00 |
| Jun 30, 2023 | 655,380.00 |
| Mar 31, 2023 | 593,613.00 |
| Dec 31, 2022 | 590,751.00 |
| Sep 30, 2022 | 590,680.00 |
| Jun 30, 2022 | 590,649.00 |
| Mar 31, 2022 | 590,208.00 |
| Dec 31, 2021 | 335,601.00 |
| Sep 30, 2021 | 589,986.00 |
| Jun 30, 2021 | 103,826.00 |